
The 10th Anniversary Liquid Biopsy for Precision Oncology Summit is the leading annual meeting organized by Hanson Wade, dedicated to accelerating the collaboration and progress of liquid biopsy technologies across the entire oncology drug development pipeline. The event, which carries the theme “Transforming Precision Therapies Through Robust Liquid Biopsy Testing,” is scheduled for February 3–5, 2026, and will be held in San Diego, California at the San Diego Marriott La Jolla. It brings together experts from pharma, biotech, diagnostics, academia, and advocacy to share insights on ctDNA, MRD (Minimal Residual Disease) monitoring, multi-omic biomarkers, and strategies for overcoming regulatory and commercial barriers to widespread clinical adoption.